Parabilis Medicines to Participate in Upcoming November Investor Conferences

CAMBRIDGE, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Parabilis Medicines (Nasdaq: PBLS), a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by unlocking historically undruggable targets, today announced that Mathai Mammen, M.D., Ph.D., Chairman, CEO and President of Parabilis Medicines, and other members of its management team, are scheduled to participate in the following investor conferences in November: * Guggenheim Healthcare Innovation Conference November 9-11, 2026, Boston, MA Fireside Chat: Monday, November 9, 2026, at 8:30 a.m. EST * Jefferies Global Healthcare Conference November 16-19, 2026, London, UK Company Presentation: Monday, November 16, 2026, at 12:30 p.m. GMT / 7:30 a.m. EST * Evercore ISI 9(th) Annual Healthcare Conference November 30 – December 2, 2026, Miami, FL Fireside Chat: Monday, November 30, 2026, at 3:50 p.m. EST Live webcasts of the fireside chats and company presentation will be available in the Investors section of the Company’s website at investors.parabilismed.com. Replays of the webcasts will be available following the events.